Legal Aspects of Pharmacotherapy: Poisons legislation , SUSMP, and Prescription Requirements
Overview: legal aspects of pharmacotherapy and interstate variations
This is the second lecture in the series on legal aspects of pharmacotherapy, focusing on poisons legislation and SUSMP (Standard for the Uniform Scheduling of Medicines and Poisons).
Key point: interstate variations exist in poisons legislation (state/territory specific), which can complicate practice when moving between NSW, Victoria, ACT, etc. Example from the speaker’s experience: practicing in Albury (NSW) and Wodonga (Victoria) with different approaches to Schedule 8 medications, their provision, and recording.
Focus for today: ACT poisons legislation, with recognition that many will practice outside the ACT; highlight notable differences across jurisdictions.
SUSMP is a federal legislative instrument produced by the Therapeutic Goods Administration (TGA) that classifies medicines/poisons into schedules, signaling the degree of control over public availability. States/territories adopt SUSMP through their own legislation to achieve uniform national regulation.
Legal drug classification and what a legal script looks like will be covered, including the role of authorized prescribers beyond medical doctors.
There are both Commonwealth and state/territory regulatory layers to medicines and poisons; the Commonwealth layer includes funding and national regulation, while states/territories regulate prescriber authorization, prescribing/dispensing requirements, and administration.
The lecture also covers funding mechanisms for medicines (MBS and PBS), and how PBS subsidies work for concession vs general patients, including RPBS for veterans.
SUSMP, TGA, and the scheduling system
SUSMP stands for the Standard for the Uniform Scheduling of Medicines and Poisons; it is a federal instrument produced by the TGA.
SUSMP defines schedules (e.g., Schedule II, III, IV, VIII) which indicate how a drug/poison should be supplied to the public and the degree of control required.
States and territories adopt SUSMP into their own poisons legislation to enable uniform regulation while allowing jurisdiction-specific differences.
The SUSMP includes extensive information beyond schedules: labeling requirements, primary packs, immediate containers, quantities, strengths, exemptions, and general regulatory guidance (advertising, storage, etc.). It is publicly accessible and essential for health professionals.
Schedules of interest for health professionals: II, III, IV, VIII. Schedule I is currently blank. Schedule V–VI–VII–IX exist in SUSMP but are less central to common health professional practice; the focus here is on II, III, IV, VIII.
Example of schedule interactions: a drug’s schedule can depend on dosage or daily limit; ibuprofen may appear in multiple schedules depending on the daily dose and formulation (e.g., 1200 mg daily as Schedule II vs higher-dose formulations as Schedule IV in some contexts).
Commonwealth legislation and national frameworks
Therapeutic Goods Administration (TGA) sits in Canberra and classifies medicines/poisons; produces SUSMP.
Therapeutic Goods Act 1988 underpins regulation of therapeutic goods; medicines in Australia are either registered (AUST R) or listed (AUST L for some products, including many complementary therapies).
A drug with an AUST R number has been assessed for safety, quality, and efficacy. Efficacy means it does what it is claimed to do.
Listed products (e.g., some complementary therapies) are considered safe and of quality but have not undergone efficacy studies by the TGA.
The TGA also produces the SUSMP instrument; SUSMP schedules are referenced by state/territory legislation for regulatory processes.
Commonwealth regulation includes the Pharmaceutical Benefits Scheme (PBS) and Medicare Benefits Schedule (MBS): two components of universal health care in Australia.
PBS: a government list of medicines subsidized for eligible Australians; the government covers the remainder of the cost beyond the patient co-payment for medicines on PBS, under the National Health Care Act of 1953.
MBS: Medicare Benefits Schedule — covers costs for consultations with GPs/hospitals; bulk-billing means a patient may pay nothing for certain services.
PBS a two-tier system: concession patients (e.g., pensioners, low-income individuals) pay a lower co-payment; general patients pay a higher co-payment.
Example with atorvastatin (Lipitor): concession co-payment ≈ ; general co-payment ≈ ; the government covers the balance to make the medicine affordable for the public.
RPBS (Repatriation Pharmaceutical Benefits Scheme) is available to eligible veterans (with gold/orange/white cards) and may include items not on PBS (e.g., sunscreen) when prescribed on a legal script under RPBS.
Medicare PBS references for funding are framed by the National Health Care Act (1953).
APRA (Australian Health Practitioner Regulation Agency) governs practitioner registration; nursing boards operate under APRA regulatory framework for nursing prescribers.
Medicines classification and prescription concepts
Medicines regulation involves both state/territory legislation and Commonwealth regulation; prescriber authorization is defined at the state/territory level and may extend beyond medical doctors to include nurse practitioners, optometrists, dentists, and midwives depending on jurisdiction.
State legislation covers: authorization of prescribers, requirements for prescribing and dispensing, administration of poisons, and schedules mapping from SUSMP.
ACT example: Medicines, Poisons and Therapeutic Goods Regulation 2008 is the current ACT poisons legislation; it describes who can deal with regulated therapeutics, definitions of regulated substances, and interplay with Commonwealth acts.
Interplay: acts/regulations can authorize dealing with regulated substances under Commonwealth or territory law; approvals may come from the Chief Health Officer or other regulatory mechanisms.
What must be on a legal prescription
A prescription must contain explicit elements to be legally valid; these requirements apply to both handwritten and computer-generated prescriptions.
Required elements typically include:
The prescriber's name, address, and contact details;
A prescriber number (a unique number assigned under PBS for the prescriber); the prescriber number should accompany the prescriber’s name and address;
The patient’s name and address; only one patient per prescription;
The date of prescription;
The medication name (and dosage form), strength, and quantity; the dose and regimen must be clear;
The signature or authorization of the prescriber (and, if applicable, professional designation);
Recognition that nurses and nurse prescribers can act as prescribers; dentists, optometrists, veterinary surgeons, and other authorized prescribers may also write prescriptions within their scope of practice.
Prescription validity: most schedule 4 medicines (prescription-only) are valid for up to twelve months, though some states/territories have variations (e.g., Northern Territory historically used shorter validity periods for certain prescriptions).
Authorization limits by prescriber type: dentists typically prescribe medicines relevant to dental care (e.g., prophylactic antibiotics) and not all medications; nurse practitioners and midwives may have broad prescribing rights within their scope.
Other medicines without a formal prescription may be supplied under pharmacist judgement (e.g., some schedule 3 pharmacist-only items) or as part of continuity of care when integrated with a prescription.
Subsidies and prescriptions: to access PBS subsidies, medicines must be on the PBS list and dispensed under a legal prescription; RPBS coverage applies to veterans with appropriate cards for additional subsidized items.
Practical note: pharmacists counsels patients and ensures labeling accuracy, application/administration directions, and potential side effects; adherence and safe use are emphasized as part of quality use of medicines.
Labeling, packaging, and storage in the SUSMP
SUSMP details labeling requirements and container specifications to ensure uniform labeling across states/territories.
Primary packs vs immediate containers: a primary pack is the original packaging produced by the manufacturer; when the quantity dispensed is less than the primary pack contents, pharmacists may repack into an immediate container with appropriate labeling.
Labeling details include quantity, strength, and directions; exemptions exist for certain packaging and labeling circumstances.
Child-resistant closures and appropriate packaging are addressed within the SUSMP.
Schedule-specific labeling and storage guidance: e.g., schedule 8 (controlled drugs) require tight storage and accounting; schedule 2–4 have different storage requirements; schedule 5–7 govern substances appropriate to their risk profiles.
Advertising and sale restrictions: the SUSMP covers the sale/supply of medicines and informs advertising restrictions (e.g., schedule 4 medicines are not advertised to the public on television).
Storage guidance emphasizes controlled drug accountability, especially for Schedule 8 medications. Pharmacists and nurses are responsible for maintaining accurate counts and preventing loss or theft, with accountability extending to each tablet or unit of a drug.
Schedules: detailed overview and examples
Schedule 1: currently blank (no medicines). Possible future changes, but presently no items.
Schedule 2: Pharmacy medicines (safe to use with pharmacist advice; available from pharmacy; not available in supermarkets).
Example: over-the-counter paracetamol in small packaging is often unscheduled, but many products requiring pharmacist advice fall under Schedule 2 (pharmacy-only medicines).
Schedule 3: Pharmacist-only medicines (require professional advice but are available from a pharmacist without a prescription).
Example: chloramphenicol eye drops (Clorsig) for bacterial conjunctivitis as a pharmacist-dispensed item after clinician assessment.
Schedule 4: Prescription-only medicines (prescription required; prescribed by any authorized prescriber).
Schedule 5: Caution (low potential for harm; can be supplied with simple warnings and packaging; often used for low-risk household products).
Schedule 6: Poison (moderate potential for harm; packaging with strong warnings; often used for agricultural or domestic products).
Schedule 7: Dangerous poison (high potential for harm; restricted to specialized or authorized users; special regulations on possession and use).
Schedule 8: Controlled drugs (for medicines with abuse potential; restricted manufacture, supply, distribution, possession and use to minimize abuse and dependence; kept under strict controls; pharmacists count tablets as they enter/leave the pharmacy; nurses must ensure no losses).
Schedule 9: Prohibited substances (substances that should be prohibited except for approved medical/scientific research or teaching with authorization).
Note: Australia follows a UK-based approach to drug scheduling, aiming to balance access and safety. There is a trend toward down-scheduling (making medicines more accessible) but with exceptions like up-scheduling codeine-containing products due to abuse concerns.
Codeine example: historically available in combination products (e.g., paracetamol-codeine) at pharmacy counters; up-scheduling occurred in recent years due to abuse, requiring a prescription for codeine-containing products when used in combination or as single-ingredient codeine (schedule 8).
Illustrative examples: osycodone (Schedule 8), ibuprofen (varies by dose into Schedule 2 or Schedule 3 or Schedule 4 depending on daily dose and formulation), and aspirin/other NSAIDs demonstrating how dosage affects scheduling.
Practical implications for nurses and health professionals
Interjurisdictional practice: if working across states/territories, you must be familiar with the specific poisons legislation for that jurisdiction (ACT example provided); ensure compliance with local regulations when administering, prescribing, or dispensing.
Prescriber authorization: prescribers include doctors, nurse practitioners, dentists, optometrists, midwives, and other authorized professionals; prescriber authority and scope depend on jurisdiction and specific legislation.
Administration of poisons: nurses are involved in the administration of schedule 2–4 medicines and schedules 8–9 with appropriate controls; knowledge of scheduling, labeling, dosage, administration routes, and safe handling is essential.
Accountability for controlled drugs: Schedule 8 drugs require strict inventory controls; pharmacists count incoming and outgoing tablets; nurses must ensure there are no losses in liquid preparations or other dosage forms.
Labeling accuracy and patient safety: pharmacists provide counseling on administration, potential side effects, and safe use; labeling must reflect dosage, frequency, and indications; health professionals should reinforce safe use and monitoring requirements.
Ethical and practical implications: balance between improving access to medicines and ensuring safety; down-scheduling increases access but may require robust safety frameworks; up-scheduling is used to curb abuse and protect public health.
Real-world relevance: the SUSMP, PBS, and MBS frameworks underpin routine practice in clinics, hospitals, and community pharmacies; understanding these elements is essential for prescribing, dispensing, and patient education.
Key takeaways to study for the exam
Australia’s poisons regulation involves both state/territory legislation and Commonwealth regulation; SUSMP is the national standard produced by the TGA and adopted by states/territories.
Understand the four main schedules relevant to health professionals: Schedule II (pharmacy medicines), Schedule III (pharmacist-only medicines), Schedule IV (prescription-only medicines), Schedule VIII (controlled drugs); Schedule I is currently blank; Schedule V–VI–VII–IX contain other categories but are less central to day-to-day practice.
Recognize the role of the PBS and MBS in funding medicines and services; the two-tier co-payment system (concession vs general) and how subsidies are calculated; RPBS for veterans provides extended coverage for certain items.
A legal prescription must include specific elements (prescriber details, patient details, date, medication information, prescriber number); prescribers can include non-doctor professionals depending on jurisdiction.
Labeling, packaging, and storage requirements are embedded in the SUSMP; primary vs immediate containers and child-resistant closures are part of good practice.
There is a continuing balance between improving access to medicines and ensuring safety; down-scheduling and up-scheduling reflect public health considerations, with notable changes such as codeine up-scheduling in recent years.
ACT-specific example: Medicines, Poisons and Therapeutic Goods Regulation 2008 outlines how medicines/poisons are regulated in ACT, with interplay between Commonwealth and territory law.
Always check jurisdiction-specific poisons legislation when practicing in a particular state/territory; the framework supports safe access and appropriate controls over medicines and poisons across Australia.
Formulas and quick references
PBS subsidy example (simplified):
If price = and concession co-payment = , general co-payment = and the medicine is PBS-listed, then the government contributes:
ext{Subsidy} = egin{cases} P - Cc, & ext{if patient is concession and } P > Cc \ P - Cg, & ext{if patient is general and } P > Cg \ 0, & ext{if } P ext{ is not greater than co-payment} \ ext{(subject to policy terms)} \ ext{and the patient pays } ext{min}(P, Cc ext{ or } Cg).
Prescriber identification and prescription validity: prescriptions are generally valid for up to twelve months for Schedule IV medicines, with potential jurisdictional variations.
Drug scheduling depends on dosage and daily limits; e.g.,
Ibuprofen: daily dose around 1200 ext{ mg}$$ can influence scheduling (examples illustrate potential Schedule II vs Schedule IV in different contexts).